SCHEMBL3626663

SCHEMBL3626663

C=CNC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1485705 0.87
SCHEMBL24290438 0.87
SCHEMBL12225902 0.86 ADH1B (0.38)
SCHEMBL1485934 0.84
SCHEMBL1485850 0.84 ADH1B (0.55)
SCHEMBL22047980 0.80
SCHEMBL10268917 0.80
SCHEMBL24289344 0.78 LMNA (0.39)
SCHEMBL13797755 0.76 POLB (0.37)
SCHEMBL21047749 0.76 ADH1B (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3562487-B1 METALLOENZYME INHIBITOR COMPOUNDS JI XING PHARMACEUTICALS HONG KONG LTD (HK) 2023-11-29 EP disclosed
EP-3983078-B1 NEXT-GENERATION MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) RYVU THERAPEUTICS S A (PL) 2023-11-15 EP disclosed
US-20230055741-A1 FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2023-02-23 US disclosed
EP-3967682-A1 BISHETEROCYCLIC CARBONYL SUBSTITUTED DIHYDROPYRAZOLE COMPOUND, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Genfleet Therapeutics (Shanghai) Inc. (CN) 2022-03-16 EP disclosed
US-20220017471-A1 FUNCTIONALITY INDEPENDENT LABELING OF ORGANIC COMPOUNDS UNIV SHANGHAI TECHNOLOGY (CN) 2022-01-20 US disclosed
EP-3577110-B1 8-OXETAN-3-YL-3,8-DIAZABICYCLO[3.2.1]OCTAN-3-YL SUBSTITUTED COMPOUNDS AS HIV INHIBITORS GILEAD SCIENCES INC (US) 2021-04-21 EP disclosed
EP-3799872-A1 TETRAHYDROQUINOLINE DERIVATIVES FOR USE AS BET INHIBITORS Forma Therapeutics, Inc. (US) 2021-04-07 EP disclosed
WO-2020249773-A1 NEXT-GENERATION MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2020-12-17 WO disclosed
WO-2020233669-A1 INDOLE DERIVATIVE-CONTAINING INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 上海翰森生物医药科技有限公司 (CN) 2020-11-26 WO disclosed
WO-2019023468-A1 TYK2 INHIBITORS AND USES THEREOF NIMBUS LAKSHMI, INC. (US) 2019-01-31 WO disclosed
CN-102947315-A Inhibitors of protein tyrosine kinase activity METHYLGENE INC 2013-02-27 CN disclosed
US-20120189539-A1 BCL-2/BCL-XL INHIBITORS AND THERAPEUTIC METHODS USING THE SAME THE REGENTS OF UNIVERSITY OF MICHIGAN (US) 2012-07-26 US disclosed
US-8114200-B2 Multi-dimensional portable gas chromatograph system VPI Enigineering, Inc. (US) 2012-02-14 US disclosed
CN-1960988-B Compounds and compositions as protein kinase inhibitors IRM LLC 2012-01-25 CN disclosed
CN-102245028-A Spiroheterocyclic N-oxypiperidines as pesticides SYNGENTA PARTICIPATIONS AG 2011-11-16 CN disclosed
CN-102177132-A Optically active vinylcyclopropanecarboxylic acid derivative and method for producing optically active vinylcyclopropaneamino acid derivative KANEGAFUCHI CHEMICAL IND 2011-09-07 CN disclosed
US-20100250146-A1 MULTI-DIMENSIONAL PORTABLE GAS CHROMATOGRAPH SYSTEM ALLIANT TECHSYSTEMS INC. (US) 2010-09-30 US disclosed
WO-2010041739-A1 OPTICALLY ACTIVE VINYL-CYCLOPROPANE CARBOXYLIC ACID DERIVATIVE AND OPTICALLY ACTIVE VINYL-CYCLOPROPANE AMINO ACID DERIVATIVE MANUFACTURING METHOD 株式会社カネカ (JP) 2010-04-15 WO disclosed
CN-1960988-A Compounds and compositions as protein kinase inhibitors IRM LLC (BM) 2007-05-09 CN disclosed
CN-1022183-C Process for preparing quinolone carboxylic acid intermediates PRIZER INC (US) 1993-09-22 CN disclosed